Iterum Therapeutics plc Quarterly Current Ratio in % from Q1 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Iterum Therapeutics plc quarterly Current Ratio history and growth rate from Q1 2019 to Q2 2024.
  • Iterum Therapeutics plc Current Ratio for the quarter ending June 30, 2024 was 150 %, a 77.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 150 -506 -77.1% Jun 30, 2024
Q1 2024 224 -575 -72% Mar 31, 2024
Q4 2023 342 -467 -57.7% Dec 31, 2023
Q3 2023 460 -322 -41.1% Sep 30, 2023
Q2 2023 656 -7.29 -1.1% Jun 30, 2023
Q1 2023 798 +338 +73.4% Mar 31, 2023
Q4 2022 809 +466 +136% Dec 31, 2022
Q3 2022 782 +555 +245% Sep 30, 2022
Q2 2022 664 +518 +356% Jun 30, 2022
Q1 2022 460 +367 +393% Mar 31, 2022
Q4 2021 343 +296 +629% Dec 31, 2021
Q3 2021 227 +184 +433% Sep 30, 2021
Q2 2021 146 +86.9 +148% Jun 30, 2021
Q1 2021 93.3 +2.16 +2.37% Mar 31, 2021
Q4 2020 47.1 -107 -69.3% Dec 31, 2020
Q3 2020 42.6 -236 -84.7% Sep 30, 2020
Q2 2020 58.8 -458 -88.6% Jun 30, 2020
Q1 2020 91.2 -755 -89.2% Mar 31, 2020
Q4 2019 154 Dec 31, 2019
Q3 2019 279 Sep 30, 2019
Q2 2019 517 Jun 30, 2019
Q1 2019 846 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.